Current Funding Opportunities
All applicants should consider submitting through the Omnibus Solicitation, which covers a broad range of NIA research topics and investigator-initiated ideas. For small businesses and research organizations working on solutions for Alzheimer’s disease (AD) and AD-related dementias (ADRD), NIA has targeted solicitations for SBIR and STTR that allow for higher budget limits of up to $500,000 for Phase I and $2.5 million for Phase II. These opportunities are part of NIA’s unprecedented research and development budget to develop AD/ADRD interventions and therapeutics.
The following opportunities are currently open:Omnibus Solicitation
2022-2 NIH SBIR Omnibus Solicitation – Clinical Trial Required
2021 NIH SBIR Omnibus Solicitation – Clinical Trial Not Allowed
Targeted Funding Opportunities
A2 Pilot Awards: AI/TECH + Aging including Alzheimer’s Disease and Related Dementia
Advancing Research on Alzheimer’s Disease (AD) and Alzheimer’s Disease-Related Dementias (ADRD)
Commercialization Support
Commercialization Readiness Pilot (CRP) Program:
For a list of all NIA SBIR and STTR funding opportunities, deadlines, and budget limits, visit the NIA Small Business Program funding page.
|